Bloomberg Markets with Carol Massar and Cory Johnson. GUEST: David Nierengarten Head of Health Care Equity Research Wedbush Securities Discussing investing in biotech stocks, inlcuding Blueprint Medicines.

Trump Says Talks Are Iran’s ‘Last Chance’ After Threats
42:36

Eight Bosses Share the Biggest Money Regrets in Their Careers
08:43

Bloomberg Businessweek Weekend: July 31st 2026
38:26